Abstract
Preimplantation genetic testing for aneuploidy (PGT-A) offers a unique opportunity to investigate genetic etiologies for impaired reproductive outcomes associated with obesity in women who undergo in vitro fertilization (IVF). It is currently unknown whether inferior IVF outcomes in obese women are caused by an impaired uterine environment, compromised oocyte quality, or a combination of the two. To date, attempts to isolate the effect of body mass index (BMI) on IVF outcomes using the donor IVF model have produced inconclusive results.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
